Company A1M Pharma AB Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 18-11-30 | |
Karin Botha
DFI | Director of Finance/CFO | 51 | 20-09-13 |
Michael Reusch
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-12-31 |
Sara Thuresson
CTO | Chief Tech/Sci/R&D Officer | 48 | 21-05-23 |
Torbjörn Larsson
PRN | Corporate Officer/Principal | - | 22-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
CHM | Chairman | 68 | 21-04-30 |
Göran Forsberg
BRD | Director/Board Member | 61 | 19-05-28 |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 22-11-30 |
Lars Höckenström
BRD | Director/Board Member | 68 | 19-10-22 |
Johannes Hulthe
BRD | Director/Board Member | 54 | 19-05-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,061,615 | 6,073,904 ( 60.37 %) | 0 | 60.37 % |
Company contact information
Guard Therapeutics International AB
Nybrogatan 34 2nd Floor
114 39, Stockholm
+46 86 70 65 51
http://www.guardtherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- GUARD Stock
- Stock
- Company A1M Pharma AB